Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades
Open Access
- 1 March 2016
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 101 (3) , 1166-1173
Abstract
Context: Thiazide diuretics, the antihypertensive agent prescribed most frequently worldwide, are commonly associated with hypercalcemia. However, the epidemiology and clinical features are poorly understood. Objective: To update the incidence of thiazide-associated hypercalcemia and clarify its clinical features. Patients and Methods: In a population-based descriptive study, Olmsted County, Minnesota, residents with thiazide-associated hypercalcemia were identified through the Rochester Epidemiology Project and the Mayo Clinic Laboratory Information System from 2002–2010 and were added to the historical cohort beginning in 1992. Main Outcome: Incidence rates were adjusted to the 2010 United States white population. Results: Overall, 221 Olmsted County residents were identified with thiazide-associated hypercalcemia an average of 5.2 years after initiation of treatment. Subjects were older (mean age, 67 years) and primarily women (86.4%). The incidence of thiazide-associated hypercalcemia increased after 1997 and peaked in 2006 with an annual incidence of 20 per 100 000, compared to an overall rate of 12 per 100 000 in 1992–2010. Severe hypercalcemia was not observed in the cohort despite continuation of thiazide treatment in 62.4%. Of patients discontinuing thiazides, 71% continued to have hypercalcemia. Primary hyperparathyroidism was diagnosed in 53 patients (24%), including five patients who underwent parathyroidectomy without thiazide discontinuation. Conclusions: Many patients with thiazide-associated hypercalcemia have underlying primary hyperparathyroidism. Additionally, a sharp rise in thiazide-associated hypercalcemia incidence began in 1998, paralleling the increase observed in primary hyperparathyroidism in this community. Case ascertainment bias from targeted osteoporosis screening is the most likely explanation.Keywords
This publication has 37 references indexed in Scilit:
- History of the Rochester Epidemiology Project: Half a Century of Medical Records Linkage in a US PopulationMayo Clinic Proceedings, 2012
- Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage systemInternational Journal of Epidemiology, 2012
- Familial hypocalciuric hypercalcaemiaCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Diuretics and Disorders of Calcium HomeostasisSeminars in Nephrology, 2011
- Use of a Medical Records Linkage System to Enumerate a Dynamic Population Over Time: The Rochester Epidemiology ProjectAmerican Journal of Epidemiology, 2011
- Differentiating Primary from Secondary Hyperparathyroidism in Stone Patients: The “Thiazide Challenge”Journal of Endourology, 2009
- Incidence and Clinical Spectrum of Thiazide-associated HypercalcemiaThe American Journal of Medicine, 2007
- Sensitivity of the Parathyroid Hormone–1, 25-Dihydroxyvitamin D Axis to Variations in Calcium Intake in Patients with Primary HyperparathyroidismNew England Journal of Medicine, 1985
- Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak.Hypertension, 1980
- CLINICAL FINDINGS IN PATIENTS WITH HYPERCALCAEMIA A Final Investigation Based on Biochemical ScreeningActa Medica Scandinavica, 1974